Institutional members access full text with Ovid®

Summaries from the XVIII World Congress of Psychiatric Genetics, Athens, Greece, 37 October 2010

Bergen, Sarah E.a; Balhara, Yatan Pal Singhe; Christoforou, Andreaf,g,h; Cole, Jamesj; Degenhardt, Franziskal,m; Dempster, Emmai; Fatjó-Vilas, Marn; Khedr, Yarao; Lopez, Lorna M.k; Lysenko, Lauraj; McGrath, Lauren M.b; Mühleisen, Thomas W.l,m; S. Neves, Fernandop; Nymberg, Charlottej; Ozomaro, Uzoezid; Verweij, Karin J.H.q; Voineskos, Aristotle N.r; Zai, Clement C.r; O'Shea, Annec; DeLisi, Lynn E.c

doi: 10.1097/YPG.0b013e3283469aa9
Commentary

The XVIIIth World Congress of Psychiatric Genetics, sponsored by The International Society of Psychiatric Genetics took place in Athens, Greece on October 3–7, 2010. Approximately 950 participants gathered to discuss the latest findings in this rapidly advancing field. The following report was written by junior travel awardees, as well as others who were volunteers from student meeting attendees. Each was assigned sessions as rapporteurs. This report represents some of the areas covered in oral presentation during the conference, and reports on some of the notable major new findings described at this 2010 World Congress of Psychiatric Genetics.

aPsychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital and Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard

bPsychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital/Harvard Medical School, Boston

cHarvard Medical School, Brockton VA Boston Healthcare System, Brockton, Massachusetts

dJohn P. Hussman Institute for Human Genomics at the University of Miami Miller School of Medicine, Florida, USA

eDepartment of Psychiatry and De-addiction Centre, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India

fBergen Mental Health Research Center

gSection for Medical Genetics and Molecular Medicine, Department of Clinical Medicine, University of Bergen, Labbygget

hDr Einar Martens' Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Helse Bergen HF, Bergen, Norway

iPsychiatric Epigenetics Group

jMRC SGDP Research Center, Institute of Psychiatry, King's College London, London

kCentre for Cognitive Ageing and Cognitive-Epidemiology, Department of Psychology, The University of Edinburgh, Edinburgh, UK

lInstitute of Human Genetics

mDepartment of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany

nDepartament de Biologia Animal, Facultat de Biologia, Universitat de Barcelona, Institut de Biomedicina de la Universitat de Barcelona (IBUB), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain

oSpecialist Psychiatrist, Heliopolis, Cairo, Egypt

pDepartamento de psiquiatria, faculdade de medicina, Universidade Federal de Minas Gerais (UFMG), MG, Brazil

qGenetic Epidemiology, Queensland Institute of Medical Research, Herston, Brisbane, Queensland, Australia

rCentre for Addiction and Mental Health, Toronto, Ontario, Canada

Correspondence to Lynn E DeLisi, MD, Harvard Medical School, Brockton VA Boston Healthcare System, 940 Belmont Street, Brockton, MA 02301, USA Tel: +1 774 826 3155; fax: +1 774 826 1758; e-mail: DeLisi76@aol.com

Anne O'Shea and Lynn E. DeLisi are coordinator and editor of reports.

Received January 10, 2011

Accepted March 9, 2011

© 2011 Lippincott Williams & Wilkins, Inc.